Non-surgical options for type 2 diabetes

The medical device industry is undergoing rapid change, driven by advances in digital health, biomaterials, and minimally invasive procedures that are redefining how chronic diseases are treated. Today’s innovators are increasingly focused on solutions that bridge the gap between traditional surgery and pharmaceutical therapy—approaches that deliver meaningful outcomes with less risk, recovery time, and cost. One example of this evolution is Morphic Medical’s RESET device, a new endoscopic technology designed to provide a non-surgical option for patients struggling with metabolic disorders such as obesity and type 2 diabetes.

The RESET system reflects a growing trend toward device-based metabolic interventions, which aim to alter physiological pathways through mechanical means rather than drugs...